>
Rise Life Science logo

RLSC - Rise Life Science Share Price

C$0.04 0.0  100.0%

Last Trade - 22/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £2.77k
Position in Universe th / 2709
Bullish
Bearish
Unlock RLSC Revenue
Momentum
Relative Strength (%)
1m +96.2%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Nov 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.009 0.000 0.000 0.19 0.97 0.032 +28.3%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 May 2021, Rise LifeScience Corp revenues decreased from C$27K to C$0K. Netincome totaled C$4.9M vs. loss of C$1.3M. Revenues reflecta decrease in demand for the Company's products andservices due to unfavorable market conditions. Net Incomereflects Interest and accretion on notes payable decreaseof 81% to C$153K (expense), Stock based compensationdecrease from C$5K (expense) to C$0K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

RLSC Revenue Unlock RLSC Revenue

Net Income

RLSC Net Income Unlock RLSC Revenue

Normalised EPS

RLSC Normalised EPS Unlock RLSC Revenue

PE Ratio Range

RLSC PE Ratio Range Unlock RLSC Revenue

Dividend Yield Range

RLSC Dividend Yield Range Unlock RLSC Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
RLSC EPS Forecasts Unlock RLSC Revenue
Profile Summary

Rise Life Science Corp, formerly Luminor Medical Technologies Inc, is a Canada-based company engaged in alternative medicine sector. The Company is focused on developing and evolving medical cannabis-based formulations to create health and well being products. The Company develops cannabis consumer products for both medical and adult use markets around the world, to address adult sexual health and wellness for both men and women. All products are based on patent pending formulations and processes to produce specific targeted effects.

Directors
Last Annual November 30th, 2020
Last Interim May 31st, 2021
Incorporated September 25, 2002
Public Since December 1, 2017
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Canadian Securities Exchange
Shares in Issue 279,662,605
Free Float (0.0%)
Eligible for
ISAs
SIPPs
RLSC Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for RLSC
Upcoming Events for RLSC
Frequently Asked Questions for Rise Life Science
What is the Rise Life Science share price?

As of 22/01/21, shares in Rise Life Science are trading at C$0.04, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Rise Life Science share price performed this year?

Shares in Rise Life Science are currently trading at C$0.04 and the price has moved by -90% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Rise Life Science price has moved by -92.14% over the past year.

What are the analyst and broker recommendations for Rise Life Science?

There are no analysts currently covering Rise Life Science.

When will Rise Life Science next release its financial results?

Rise Life Science is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-05-31
What is the Rise Life Science dividend yield?

Rise Life Science does not currently pay a dividend.

Does Rise Life Science pay a dividend?

Rise Life Science does not currently pay a dividend.

When does Rise Life Science next pay dividends?

Rise Life Science does not currently pay a dividend.

How do I buy Rise Life Science shares?

To buy shares in Rise Life Science you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Rise Life Science?

Shares in Rise Life Science are currently trading at C$0.04, giving the company a market capitalisation of £n/a.

Where are Rise Life Science shares listed? Where are Rise Life Science shares listed?

Here are the trading details for Rise Life Science:

Country of listing: Canada
Exchange: CNX
Ticker Symbol: RLSC
What kind of share is Rise Life Science?

We were not able to load our ranking data for Rise Life Science

Is there a Rise Life Science share price forecast 2021?

We were not able to load any forecast data for Rise Life Science.

How can I tell whether the Rise Life Science share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Rise Life Science. Over the past six months, the relative strength of its shares against the market has been -63.47%. At the current price of C$0.04, shares in Rise Life Science are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Rise Life Science PE Ratio?

We were not able to find PE ratio data for Rise Life Science.

Who are the key directors of Rise Life Science?

Rise Life Science's management team is headed by:

Christopher Carmichael - CFO
Ashwath Mehra - DRC
Daniel Cloutier - DRC
Ryan Rocca - CEO
Scott Secord - CHM
Greg Mills - DRC
Who are the major shareholders of Rise Life Science?

Here are the top five shareholders of Rise Life Science based on the size of their shareholding:

Secord (Scott Lawrence) Individual Investor
Percentage owned: 14.38% (40.2m shares)
Mehra (Ashwath) Individual Investor
Percentage owned: 3.58% (10.0m shares)
Similar to RLSC
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.